Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidal Essebag

Showing results (61-70 of 185) with videos related to

Pageof 19
Sort By:
Archives of Internal Medicine|August 19, 2007
Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillationVidal Essebag, Matthew R Reynolds, Tom Hadjis, et al.
JAMA Internal Medicine|December 26, 2012
Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter studyAtul Verma, Jean Champagne, John Sapp, et al.
European Heart Journal|September 27, 2005
Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillationVidal Essebag, Ferdinando Baldessin, Matthew R Reynolds, et al.
The American Journal of Cardiology|March 27, 2018
Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization TherapyAhmed AlTurki, Riccardo Proietti, Hasan Alturki, et al.
Archives of Internal Medicine|June 6, 2012
Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillationRaluca Ionescu-Ittu, Michal Abrahamowicz, Cynthia A Jackevicius, et al.
The Canadian Journal of Cardiology|May 7, 2011
In-hospital management of atrial fibrillation: the CHADS₂ score predicts increased costMark A Kotowycz, Kristian B Filion, Jacqueline Joza, et al.
The Canadian Journal of Cardiology|February 4, 2018
Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial FibrillationYang Zhan, Jacqueline Joza, Mohamed Al Rawahi, et al.
Minerva Cardioangiologica|February 28, 2017
Pattern of initiation of monomorphic ventricular tachycardia and implications on tachycardia mechanismRodrigo S Barbosa, Leon Glass, Riccardo Proietti, et al.
Medical Devices (Auckland, N.Z.)|February 14, 2015
Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trialsRiccardo Proietti, Jacqueline Joza, Andrea Arensi, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 29, 2021
Comparative effectiveness of ventricular tachycardia ablation vs. escalated antiarrhythmic drug therapy by location of myocardial infarction: a sub-study of the VANISH trialMichelle Samuel, Lena Rivard, Isabelle Nault, et al.
Pageof 19

Showing results (61-70 of 185) with videos related to

Sort By:
Pageof 19
Archives of Internal Medicine|August 19, 2007
Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillationVidal Essebag, Matthew R Reynolds, Tom Hadjis, et al.
JAMA Internal Medicine|December 26, 2012
Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter studyAtul Verma, Jean Champagne, John Sapp, et al.
European Heart Journal|September 27, 2005
Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillationVidal Essebag, Ferdinando Baldessin, Matthew R Reynolds, et al.
The American Journal of Cardiology|March 27, 2018
Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization TherapyAhmed AlTurki, Riccardo Proietti, Hasan Alturki, et al.
Archives of Internal Medicine|June 6, 2012
Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillationRaluca Ionescu-Ittu, Michal Abrahamowicz, Cynthia A Jackevicius, et al.
The Canadian Journal of Cardiology|May 7, 2011
In-hospital management of atrial fibrillation: the CHADS₂ score predicts increased costMark A Kotowycz, Kristian B Filion, Jacqueline Joza, et al.
The Canadian Journal of Cardiology|February 4, 2018
Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial FibrillationYang Zhan, Jacqueline Joza, Mohamed Al Rawahi, et al.
Minerva Cardioangiologica|February 28, 2017
Pattern of initiation of monomorphic ventricular tachycardia and implications on tachycardia mechanismRodrigo S Barbosa, Leon Glass, Riccardo Proietti, et al.
Medical Devices (Auckland, N.Z.)|February 14, 2015
Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trialsRiccardo Proietti, Jacqueline Joza, Andrea Arensi, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 29, 2021
Comparative effectiveness of ventricular tachycardia ablation vs. escalated antiarrhythmic drug therapy by location of myocardial infarction: a sub-study of the VANISH trialMichelle Samuel, Lena Rivard, Isabelle Nault, et al.
Pageof 19